A heterogeneous human immunodeficiency virus-like particle (VLP) formulation produced by a novel vector system
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2059-0105
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
A heterogeneous human immunodeficiency virus-like particle (VLP) formulation produced by a novel vector system ; volume:3 ; number:1 ; day:19 ; month:1 ; year:2018 ; pages:1-10 ; date:12.2018
npj vaccines ; 3, Heft 1 (19.1.2018), 1-10, 12.2018
- Urheber
-
Pankrac, Joshua
- Beteiligte Personen und Organisationen
-
Klein, Katja
McKay, Paul F.
King, Deborah F. L.
Bain, Katie
Knapp, Jason
Biru, Tsigereda
Wijewardhana, Chanuka N.
Pawa, Rahul
Canaday, David H.
Gao, Yong
Fidler, Sarah
Shattock, Robin J.
Arts, Eric J.
Mann, Jamie F. S.
SpringerLink (Online service)
- DOI
-
10.1038/s41541-017-0040-6
- URN
-
urn:nbn:de:1111-201803183186
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:51 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Pankrac, Joshua
- Klein, Katja
- McKay, Paul F.
- King, Deborah F. L.
- Bain, Katie
- Knapp, Jason
- Biru, Tsigereda
- Wijewardhana, Chanuka N.
- Pawa, Rahul
- Canaday, David H.
- Gao, Yong
- Fidler, Sarah
- Shattock, Robin J.
- Arts, Eric J.
- Mann, Jamie F. S.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Safety and immunogenicity of plant-produced African horse sickness virus-like particles in horses
Plant-produced chimeric virus-like particles - a new generation vaccine against African horse sickness
Immunogenicity and virus-like particle formation of rotavirus capsid proteins produced in transgenic plants
Extended Variational Formulation for Heterogeneous Partial Differential Equations
Trans-packaging of human immunodeficiency virus type 1 genome into Gag virus-like particles in Saccharomyces cerevisiae
Humoral immune response induced with dengue virus-like particles serotypes 1 and 4 produced in silkworm
Preclinical evaluation of manufacturable SARS-CoV-2 spike virus-like particles produced in Chinese Hamster Ovary cells
Primary immunodeficiency
Ebola virus–like particles reprogram cellular metabolism
A Particle-Surface-Area-Based Formulation of Heterogeneous Ice Nucleation by Mineral Dust Aerosols
Virus-like infection induces human β cell dedifferentiation
Virus-like particle vaccinology, from bench to bedside
Safety and immunogenicity of plant-produced African horse sickness virus-like particles in horses
Plant-produced chimeric virus-like particles - a new generation vaccine against African horse sickness
Immunogenicity and virus-like particle formation of rotavirus capsid proteins produced in transgenic plants
Extended Variational Formulation for Heterogeneous Partial Differential Equations
Trans-packaging of human immunodeficiency virus type 1 genome into Gag virus-like particles in Saccharomyces cerevisiae
Humoral immune response induced with dengue virus-like particles serotypes 1 and 4 produced in silkworm
Preclinical evaluation of manufacturable SARS-CoV-2 spike virus-like particles produced in Chinese Hamster Ovary cells
Primary immunodeficiency
Ebola virus–like particles reprogram cellular metabolism
A Particle-Surface-Area-Based Formulation of Heterogeneous Ice Nucleation by Mineral Dust Aerosols
Virus-like infection induces human β cell dedifferentiation
Virus-like particle vaccinology, from bench to bedside
Safety and immunogenicity of plant-produced African horse sickness virus-like particles in horses
Plant-produced chimeric virus-like particles - a new generation vaccine against African horse sickness
Immunogenicity and virus-like particle formation of rotavirus capsid proteins produced in transgenic plants
Extended Variational Formulation for Heterogeneous Partial Differential Equations
Trans-packaging of human immunodeficiency virus type 1 genome into Gag virus-like particles in Saccharomyces cerevisiae
Humoral immune response induced with dengue virus-like particles serotypes 1 and 4 produced in silkworm
Preclinical evaluation of manufacturable SARS-CoV-2 spike virus-like particles produced in Chinese Hamster Ovary cells
Primary immunodeficiency
Ebola virus–like particles reprogram cellular metabolism
A Particle-Surface-Area-Based Formulation of Heterogeneous Ice Nucleation by Mineral Dust Aerosols
Virus-like infection induces human β cell dedifferentiation